Can India repeat the success of generics in US (United States) biosimilar market? an analysis of current FDA's stand on biosimilars

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{ce5fc66ff1d44b2dbbb237fdb16413bc,

title = "Can India repeat the success of generics in US (United States) biosimilar market? an analysis of current FDA's stand on biosimilars",

author = "S. Moorkoth and Y. Gujar and D. Bukka",

note = "cited By 0",

year = "2013",

language = "Undefined/Unknown",

volume = "45",

pages = "27--31",

journal = "Pharma Times",

issn = "0031-6849",

publisher = "Indian Pharmaceutical Association",

number = "1",

}